Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

Key Inclusion Criteria:

   - Male or female from 1-3 years of age;

   - Physician-diagnosed peanut allergy;

   - Peanut-specific IgE level > 0.7 kU/L;

   - Positive peanut SPT with a largest wheal diameter ≥ 6 mm;

   - Positive DBPCFC at ≤ 300 mg peanut protein;

Key Exclusion Criteria:

   - Uncontrolled asthma;

   - History of severe anaphylaxis to peanut;

   - Prior immunotherapy to any food or other immunotherapy;

   - Generalized severe dermatologic disease;